title: [Treatment of Lewy body dementia].
abstract: Lewy body dementia (LBD) is more frequent than previously considered and is characterized by the scarcity of therapeutic resources and the difficulty of treatment since many patients are hypersensitive to neuroleptics. Although further research is required in this field, standardization of the diagnostic criteria has improved the data obtained from research. Currently, anticholinesterase drugs have proven utility in LBD and there is increasing evidence that memantine can also be useful. Typical neuroleptics are dangerous in these patients and should never be used. Among atypical neuroleptics, quetiapine is the best option, although conclusive data are lacking.
authors.affiliation: Área de Psicogeriatría, CASM Hospital Benito Menni, Sant Boi de Llobregat, Barcelona, España. 33365prd@comb.cat
authors.forename: Pedro J Regalado
authors.initials: PJ
authors.lastname: Doña
mesh_terms: D000368:Aged; D006801:Humans; D020961:Lewy Body Disease / Q000150:complications / Q000188:drug therapy*